Search Results 11-20 of 11418 for %EC%B2%9C%EC%95%88%EC%BD%9C%EA%B1%B8%E3%80%90%EC%B9%B4%ED%86%A1%EC%83%81%EB%8B%B4:vB20%E3%80%91
About this study. This is a prospective, phase II trial to assess feasibility of patients undergoing NSM willingness to be randomized to neurotization or ...
About this study. The purpose of this study is to compare rectal emptying and rectoanal pressures in healthy people and DD. Our hypotheses are that (i) the ...
Mayo Clinic Center for Individualized Medicine's Pharmacogenomics Program studies how people's specific DNA sequences influence their responses to ...
The general aim of this study is to estimate the rate of disease progression for adults who seek testing and test positive for SARS-CoV-2. The primary endpoint ...
Congress of Neurological Surgeons CNS - Education.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Talk to a healthcare professional about taking one or more medicines. 140 or higher, or, 90 or higher, Stage 2 hypertension, Maintain or adopt a healthy ...
... EA ADD HR,125,150, 260000007,HC IV INF THER INIT 1ST HR,400,460, 260000008,HC IV PUSH EA ADD SEQ DRUG,108,143, 260000009,HC IV PUSH EA ADD SEQ NEW DRUG ...
... 88 mcg tablet,9.24 637000000,378180777 ... 90 mg tablet,23.09 637000000,536430608,calcium ... B2) 100 mg tablet,2.04 637000000,11845071401,riboflavin ...
A Study of Safety, Tolerability, Pharmacokinetic and Pharmacodynamics (PK/PD) in Patients With Hematologic Malignancies · More about research at Mayo Clinic.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.